Latvia vs Montenegro: Colon and rectum cancer screening coverage in Europe
Latvia
28.0%
in 2025
Montenegro
22.7%
in 2024
Latvia rank
16th
Montenegro rank
17th
Colon and rectum cancer screening coverage in Europe over time
- Latvia
- Montenegro
How they compare
Latvia currently reports 28.0% against 22.7% in Montenegro, a difference of 5.3%.
That makes Latvia's figure about 1.2 times Montenegro's.
The two have swapped places 1 time across 6 shared years of data; in 2019 it was Montenegro ahead.
Latvia ranks 16th and Montenegro ranks 17th of 20 countries.
Across the 2 decades both report, Latvia averaged higher in 1 and Montenegro in 1.
Head to head by decade
| Decade | Latvia | Montenegro | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 15.0% | 23.7% | 8.7% | Montenegro |
| 2020s | 20.8% | 9.7% | 11.1% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher colon and rectum cancer screening coverage in europe, Latvia or Montenegro?
- Latvia, at 28.0% against 22.7% in Montenegro as of 2025.
- What is the difference in colon and rectum cancer screening coverage in europe between Latvia and Montenegro?
- 5.3%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Montenegro?
- 6 years are reported by both, from 2019 to 2024.
- How do Latvia and Montenegro rank globally for colon and rectum cancer screening coverage in europe?
- Latvia ranks 16th and Montenegro ranks 17th of 20 countries.
- Where does this data come from?
- Eurostat (2026) – with minor processing by Our World in Data, published as Colon and rectum cancer screening coverage in Europe. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of people aged 50 to 74 years who have been screened for colon and rectum cancer within the previous 2 years.